Log in to search using one of your social media accounts:


Are Pilates Good for Parkinson's Disease?

Title: Are Pilates Good for Parkinson's Disease?Category: Doctor's&Expert's views on SymptomsCreated: 7/14/2017 12:00:00 AMLast Editorial Review: 7/14/2017 12:00:00 AM
Source: MedicineNet Exercise and Fitness General - Category: Podiatry Source Type: news

Related Links:

AbstractPage 303, column 2, paragraph 1, lines 1-4: the following sentence, which previously read:
Source: Drugs and Therapy Perspectives - Category: Drugs & Pharmacology Source Type: research
AbstractParkinson ’s disease (PD) is the most common chronic, progressive, neurodegenerative disease, with a mean age of onset of 57 years [1, 2].
Source: Drugs - Category: Drugs & Pharmacology Source Type: research
A new 'tele-empathy' device allows Pat Smerdon of Vancouver to experience the same Parkinson's tremors that his twin brother, Jim, struggles with every day.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Conditions:   Parkinson Disease;   Surgery Interventions:   Procedure: Neural implantation group;   Procedure: Sham surgery Sponsor:   University of Denver Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
US civil rights activist Jesse Jackson disclosed that he has been diagnosed with Parkinson ’s disease. Unfortunately for Jackson, and more than 10 million worldwide living with Parkinson's, there's no cure. However, a new partnership between AstraZeneca and Berg believes AI will be able to prevent it
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: NASDAQ:AZN NASDAQ:BERG NASDAQ:GSK Source Type: news
(Reuters) - Acorda Therapeutics Inc said on Monday it would stop developing its Parkinson's disease drug, less than a week after the company reported deaths in key studies testing the treatment.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Previous postmortem studies demonstrated dysregulation of autophagy in patients with Parkinson's disease (PD). To clarify whether this alteration reflects a fundamental aspect of PD or represents the final stage of autophagy dysregulation resulting from a long neurodegenerative process, we focused on basal autophagy in peripheral blood mononuclear cells (PBMCs) of PD patients (n = 35) and controls (n = 23). The whole-transcriptome assay revealed down-regulation of mRNAs for six core regulators of autophagy (UNC-51-like kinase (ULK) 3, autophagy-related (Atg) 2A, Atg4B, Atg5, Atg16L1, histone deacetylase 6).
Source: Neurobiology of Aging - Category: Neuroscience Authors: Source Type: research
Parkinson ’s disease [PD] affects 3% of the population over the age of 65-years, with a slight male predominance; however up to 10% of patients develop symptoms before the age of 40 years.1 Estimates of prevalence rates of PD in European countries range from 65.6 to 12 500 per 100 000 and annual incidence e stimates range from 5 to 346 per 100 000.2 The prevalence of PD among women of child-bearing age is unknown, and pregnancy in women with PD is very uncommon. According to the available estimates, about 5% of PD patients fall within the childbearing age group.
Source: International Journal of Obstetric Anesthesia - Category: Anesthesiology Authors: Tags: Case report Source Type: research
Radiology,Volume 285, Issue 3, Page 725-727, December 2017.
Source: Radiology - Category: Radiology Authors: Source Type: research
ConclusionThe prolongedt1/2, increased AUC0 –t, and more stable plasma drug concentration of the rasagiline patch may permit a longer dosing interval compared to the oral tablet. The rasagiline transdermal patch was safe and well tolerated in healthy Chinese subjects.
Source: Clinical Drug Investigation - Category: Drugs & Pharmacology Source Type: research
More News: Parkinson's Disease | Podiatry | Sports Medicine